- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07585578
Multidimensional Dysfunction in Patients With Post-Intensive Care Syndrome in China: A Multi-center Real-world Study
May 8, 2026 updated by: Hongying Jiang, MD
Over the past two decades, the rapid advancement of critical care medicine has significantly reduced short-term mortality among critically ill patients.
However, a growing number of intensive care unit (ICU) survivors experience persistent physical, cognitive, and psychological impairments after hospital discharge, a syndrome termed post-intensive care syndrome (PICS).
Although PICS has gained increasing attention in recent years, existing studies still have multiple limitations.
Given the continuously increasing number of ICU survivors in China and the marked heterogeneity in critical care delivery models across different regions and healthcare institutions, there is an urgent need for large-scale multicenter observational studies to systematically characterize the epidemiological features, multidimensional functional impairment profiles, and clinical impact of PICS in Chinese patients, thereby providing an evidence-based foundation for the development of a scientific post-ICU continuum of care.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
This multi-center observational study aims to characterize the epidemiological profile and multidimensional functional impairments of Post-Intensive Care Syndrome (PICS) in ICU survivors across China.
The study will enroll approximately 800 participants from six participating centers (three high-dependency units from 2018-2026 and three ICUs from 2025-2026).
Data on physical, cognitive, and psychological function will be collected using validated assessment tools including MRC, ICU Mobility Scale, CPAx, MMSE, S5Q, PHQ-9, GAD-7, PSQI, Barthel Index, and EQ-5D-5L.
Primary outcomes include the incidence of PICS and comorbidity patterns across multiple functional domains.
Secondary outcomes encompass functional status, quality of life, and risk factors for PICS.
Study Type
Observational
Enrollment (Estimated)
800
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Jingyi Ge
- Phone Number: +861056981098
- Email: ge_jingyi2020@163.com
Study Contact Backup
- Name: Hongying Jiang, MD
- Phone Number: +861056981098
- Email: 6jhy@163.com
Study Locations
-
-
Beijing Municipality
-
Beijing, Beijing Municipality, China, 100043
- Beijing Rehabilitation Hospital, Capital Medical University, Beijing,China
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
This study is a multi-center, retrospective, observational cohort study that will enroll patients from six participating centers across China, including three high-dependency units (HDUs) and three ICUs.
For the HDU component, patients transferred from general hospital ICUs to the participating HDUs between January 2018 and January 2026 will be screened.
For the ICU component, patients scheduled for discharge directly from the participating ICUs between January 2025 and January 2026 will be screened.
Data will be sourced from medical records, nursing records, rehabilitation assessment records, and follow-up documentation from routine clinical care.
The anticipated total sample size is 800 participants.
Description
Inclusion Criteria:
- Age ≥18 years
- Admitted to ICU from participating general hospitals and transferred to participating High-Dependency Units (HDUs) or discharged directly from participating ICUs
- First ICU admission with ICU length of stay ≥48 hours
- Complete clinical data available (demographics, ICU-related information)
- Signed informed consent obtained from participants or legal guardians
Exclusion Criteria:
- Prior ICU admission
- Terminal illness or estimated life expectancy <6 months
- Participants or family members refuse to complete questionnaires
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
post-intensive care syndrome group
PICS patients who come from a general hospital ICU and are transferred to a participating HDU, or who are planned for discharge from a participating ICU.
|
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
MRC Sum Score for Muscle Strength
Time Frame: Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
MRC (Medical Research Council) sum score assessing muscle strength.
Total score ranges from 0 (complete quadriplegia) to 60 (normal bilateral muscle strength).
Higher scores indicate better muscle strength.
|
Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
|
ICU Mobility Scale Score
Time Frame: Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
ICU Mobility Scale (IMS) assessing mobility level in ICU patients.
Total score ranges from 0 (lying in bed, not active) to 10 (walking independently).
Higher scores indicate better mobility.
|
Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
|
Chelsea Critical Care Physical Assessment Tool Score
Time Frame: Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
Chelsea Critical Care Physical Assessment Tool (CPAx) comprehensively evaluating physical function in ICU patients.
Total score ranges from 0 to 50.
Higher scores indicate better physical function.
|
Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
|
Mini-Mental State Examination Score
Time Frame: Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
Mini-Mental State Examination (MMSE) assessing cognitive function.
Total score ranges from 0 to 30.
Higher scores indicate better cognitive function.
(Chinese validated version will be used.)
|
Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
|
PHQ-9 Score for Depression
Time Frame: Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
Patient Health Questionnaire-9 (PHQ-9) assessing severity of depressive symptoms.
Total score ranges from 0 to 27 (0-4: none, 5-9: mild, 10-14: moderate, 15-19: moderately severe, 20-27: severe).
Higher scores indicate worse depression.
|
Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
|
GAD-7 Score for Anxiety
Time Frame: Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
Generalized Anxiety Disorder 7-item scale (GAD-7) assessing severity of anxiety symptoms.
Total score ranges from 0 to 21 (0-4: none, 5-9: mild, 10-14: moderate, 15-21: severe).
Higher scores indicate worse anxiety.
|
Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
|
Pittsburgh Sleep Quality Index Global Score
Time Frame: Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
Pittsburgh Sleep Quality Index (PSQI) assessing sleep quality.
Global score ranges from 0 to 21.
Higher scores indicate worse sleep quality.
|
Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
|
Brief Pain Inventory-9 Pain Severity Score
Time Frame: Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
Brief Pain Inventory-9 (BPI-9) pain severity score.
Total score ranges from 0 to 10. Higher scores indicate more severe pain.
|
Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
|
Hospital Anxiety and Depression Scale Score for Family Caregivers
Time Frame: Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
Hospital Anxiety and Depression Scale (HADS) assessing psychological status of family caregivers.
Each subscale (anxiety and depression) ranges from 0 to 21.
Higher scores indicate worse psychological distress.
|
Collect data within 24 hours after admission to the HDU or within 24 hours before discharge from the ICU.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 10, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
May 31, 2027
Study Registration Dates
First Submitted
May 1, 2026
First Submitted That Met QC Criteria
May 8, 2026
First Posted (Actual)
May 14, 2026
Study Record Updates
Last Update Posted (Actual)
May 14, 2026
Last Update Submitted That Met QC Criteria
May 8, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
- postintensive care syndrome
- Health Care Quality, Access, and Evaluation
- Investigative Techniques
- Epidemiologic Methods
- Therapeutics
- Health Care Evaluation Mechanisms
- Quality of Health Care
- Public Health
- Environment and Public Health
- Behavior Control
- Immobilization
- Restraint, Physical
- Data Collection
Other Study ID Numbers
- 2026bkky-dzx-PICS
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-Intensive Care Syndrome (PICS)
-
COEN MatteoRecruitingPost Intensive Care Syndrome (PICS)Switzerland
-
Zealand University HospitalNot yet recruitingPost-Intensive Care Syndrome (PICS) | Intensive Care Unit (ICU) Patients | Symptom Burden
-
Hongying Jiang, MDNot yet recruitingMechanical Ventilation | Post-Intensive Care Syndrome (PICS) | Critical Illness RecoveryChina
-
Malcom Randall VA Medical CenterRecruitingPost Intensive Care Syndrome (PICS)United States
-
KK Women's and Children's HospitalNational University Hospital, Singapore; Duke-NUS Graduate Medical School; Singapore...Recruiting
-
Centre Hospitalier Universitaire DijonRecruitingPost Intensive Care Syndrome (PICS)France
-
Carola Giménez-Esparza VichRecruitingCritical Illness | Post Intensive Care Syndrome (PICS)Spain
-
ARH van Zanten, MD PhDWageningen University and Research; TKI Agri & Food; Danone Global Research &...RecruitingPost-Intensive Care Syndrome (PICS)Netherlands
-
Radboud University Medical CenterRecruitingPost-Intensive Care Syndrome (PICS)Netherlands
-
Medical University of ViennaRecruitingPost-Intensive Care Syndrome (PICS)Austria
Clinical Trials on Data Collection and Assessment
-
Taras Shevchenko National University of KyivNot yet recruitingReproductive Behavior | Cohort Studies | Women | Perinatal Mental HealthUkraine
-
University Hospital, Basel, SwitzerlandRecruitingCardiomyopathy | Arrhythmia-induced Cardiomyopathy (AiCM)Switzerland
-
University Hospital, Basel, SwitzerlandRecruitingInfections With CPBSwitzerland
-
Care Management PlusCompletedHealth Information Technology | Nurse Based Care ManagementUnited States
-
Xuanwu Hospital, BeijingRecruitingMultiple Sclerosis | Myasthenia Gravis | Autoimmune Encephalitis | Acute Disseminated Encephalomyelitis | NMO Spectrum Disorder | Myelin Oligodendrocyte Glycoprotein Antibody-associated DiseaseChina
-
Vanda PharmaceuticalsRecruitingSleep-wake Disorder in Blind IndividualsUnited States
-
M.D. Anderson Cancer CenterUnknownPediatric CancerUnited States
-
GlaxoSmithKlineCompletedInfections, StreptococcalRomania, Slovenia, Poland, Lithuania, Estonia
-
GlaxoSmithKlineWithdrawnHuman Papillomavirus Infection
-
University Hospital, Basel, SwitzerlandCompletedHamstring Muscle Repair | Hamstring RuptureSwitzerland